Steps forward, backward, and sideways: Canada’s bill on exporting generic pharmaceuticals – HIV/AIDS Policy and Law Review 9(3)

This article is the second in a series tracing the evolution of Canada’s legislation. It reviews the developments leading up to the adoption of Bill C-9 in its final form, and analyzes its positive and negative aspects. Hopefully, other advocates can learn from this experience and other countries can avoid replicating the negative aspects as they implement the WTO Decision.

This entry was posted in English, French, Journal Articles, Publications. Publication Topics: . Bookmark the permalink. Both comments and trackbacks are currently closed.
Doc Type